SARS-CoV-2 antibodies
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
... of SARS-CoV-2 antibodies in ...of SARS-CoV-2 antibodies in the French population by age group and collection ...of SARS-CoV-2 antibodies ...
8
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ...
8
High seroprevalence of SARS-CoV-2 antibodies among people living in precarious situations in Ile de France
... of SARS-COV2 antibodies were performed using the LuLISA (Luciferase-Linked Immunosorbent Assay) technology designed by Institut Pasteur, Paris ...the SARS-CoV-2 virus, or the Spike (S) ...
26
Compromised SARS-CoV-2-specific placental antibody transfer
... in SARS- CoV-2 infection Preferential transfer of agalactosylated/afucosylated SARS- CoV-2 antibodies points to a critical role for FCGR3A selection during placental ...
27
PTSD as the second tsunami of the SARS-Cov-2 pandemic
... of SARS is generating a great anxiety contributing to promote ...the SARS-Cov-2 pandemic, both for general population, patients, and healthcare ...
3
Distinct systemic and mucosal immune responses to SARS-CoV-2
... following SARS-CoV-2 infection and the individual roles that they play in determining severe clinical outcomes in a minority of COVID-19 ...active SARS-CoV-2 infection in a well ...
41
View of SARS-CoV-2 in Pediatric Intensive Care Unit
... à SARS-CoV-2 qui a frappé la France à partir du mois de mars 2020, a été moins sévère pour les enfants que pour les adultes, et ce malgré des antécédents parfois ...infection ...
16
Tracing the origins of SARS-CoV-2 in coronavirus phylogenies
... of SARS-CoV-2: (i) adaptation in an animal host before zoonotic transfer, or (ii) adaptation in humans after zoonotic transfer (Latinne et ...that SARS-CoV-2 may have been ...
33
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
... (step 2) and extraction buffer was aspirated (step ...202 SARS‑CoV‑2–positive nasopharyngeal swab samples obtained from patients and detected by means of a fluores‑ cence readout and measured ...
5
Preparing for emerging respiratory pathogens such as SARS-CoV, MERS-CoV, and SARS-CoV-2.
... N-95 and Respirator Training and Availability N-95 respirators are important parts of the per- sonal protective equipment during the care of pa- tients requiring airborne infection isolation (AII) precautions. The ‘N’ ...
8
Chaos game representation dataset of SARS-CoV-2 genome
... The dataset provides two groups of formats files for all data. In the first group, all data are stored in Matlab file format (.mat), and in the second group, part of the data is stored in Mi- crosoft Excel (.xlsx) and ...
6
Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH
... Visualizing SARS-CoV-2 with CoronaFISH (a) Principle of ...the SARS-CoV-2 positive or negative ...of SARS-CoV-2 with indicated probe positions targeting the ...
26
Evolution of viral quasispecies during SARS-CoV-2 infection
... Supplementary Table 2: Characteristics of the nasopharyngeal and induced sputum samples with effective amplification and next generation sequencing. Ct: cycle threshold; del: deletion; fs: frameshift; IQR: ...
36
Challenges and Issues of Anti-SARS-CoV-2 Vaccines
... concerns arose about allergic reactions following administration of the Pfizer vaccine, mainly due to the lipid envelop necessary to transport the nucleic acid. Despite the media impact, the rate of anaphylaxis observed ...
12
Editorial SARS-CoV-2 et COVID-19 : pas au bout des doutes, questionnements et controverses.
... Il est heu- reux de constater qu’après des balbutiements ini- tiaux, bien compréhensibles face à une maladie inédite, des progrès considérables ont été accom- plis dans la prise en char[r] ...
5
Estimating the burden of SARS-CoV-2 in France
... We use a deterministic compartmental model stratified by age to describe the transmission of SARS- CoV-2 in the French population. Upon infection, susceptible individuals will enter a latent ...
44
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
... Methods Ethics and biosafety statement Cynomolgus macaques (M. fascicularis), aged 37–40 months and origi- nating from Mauritian AAALAC-certified breeding centres, were used in this study. All macaques were housed in ...
19
Cibler la protéase majeure du SARS-CoV-2 pour fabriquer un médicament efficace contre ce coronavirus
... Le principe d’action des molécules bloquant les protéases est schéma- tisé dans la Figure 2 . Des inhibiteurs de la protéase 3CL pro des coronavi- rus déjà connus ont été testés pour leur capacité à inhiber celle ...
5
Seroepidemiologic study designs for determining SARS-COV-2 transmission and immunity
... Cross-Sectional Studies Cross-sectional studies measure prevalence of an- tibody responses in a sample of the population at a single time point. These studies might be repeated at multiple time points (a repeated ...
10
Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant
... of SARS-CoV-2 mutants in the Netherlands in April ( Oude Munnink et ...culled. SARS-CoV-2 is an epizootic agent that caused an outbreak in humans before being transferred to mink ...
10